Bluejay Diagnostics (BJDX) Change in Accured Expenses (2022 - 2023)

Historic Change in Accured Expenses for Bluejay Diagnostics (BJDX) over the last 2 years, with Q4 2023 value amounting to -$967215.0.

  • Bluejay Diagnostics' Change in Accured Expenses fell 75247.98% to -$967215.0 in Q4 2023 from the same period last year, while for Dec 2023 it was -$30279.0, marking a year-over-year decrease of 10899.5%. This contributed to the annual value of -$695653.0 for FY2024, which is 219747.68% down from last year.
  • Bluejay Diagnostics' Change in Accured Expenses amounted to -$967215.0 in Q4 2023, which was down 75247.98% from $463956.0 recorded in Q3 2023.
  • Bluejay Diagnostics' 5-year Change in Accured Expenses high stood at $487141.0 for Q2 2023, and its period low was -$967215.0 during Q4 2023.